0187-4330 : Isuprel .2 mg/ml Intracardiac; Intramuscular; Intravenous; Subcutaneous Injection, Solution


NDC: 0187-4330
Labeler: Valeant Pharmaceuticals North America LLC
Product Type: Human Prescription Drug
Drug Name:  Isuprel
Dosage Form: Intracardiac; Intramuscular; Intravenous; Subcutaneous Injection, Solution
Application #: NDA010515
Rev. Date: 


NDC Package Codes:

  • 0187-4330-01: 25 AMPULE IN 1 CARTON (0187‑4330‑01) > 1 ML IN 1 AMPULE
  • 0187-4330-05: 10 AMPULE IN 1 CARTON (0187‑4330‑05) > 5 ML IN 1 AMPULE

Active Ingredients:

  • Isoproterenol Hydrochloride

Dosage Strength:

  • .2 mg/mL

Pharmaceutical Classes:

  • Adrenergic beta-Agonists [MoA]
  • beta-Adrenergic Agonist [EPC]

Related Products:

Based on records with the same trade name.
  • 0409-1410 Isuprel .2 mg/ml Intracardiac; Intramuscular; Intravenous; Subcutaneous Injection, Solution by Hospira, Inc.
  • 0409-1442 Isuprel .2 mg/ml Intracardiac; Intramuscular; Intravenous; Subcutaneous Injection, Solution by Hospira, Inc.
  • 42998-402 Isuprel .2 mg/ml Intracardiac; Intramuscular; Intravenous; Subcutaneous Injection, Solution by Marathon Pharmaceuticals, LLC
  • 52584-021 Isuprel .2 mg/ml Intracardiac; Intramuscular; Intravenous; Subcutaneous Injection, Solution by General Injectables & Vaccines, Inc
  • 55154-4729 Isuprel .2 mg/ml Intracardiac; Intramuscular; Intravenous; Subcutaneous Injection, Solution by Cardinal Health
  • 55154-6988 Isuprel .2 mg/ml Intracardiac; Intramuscular; Intravenous; Subcutaneous Injection, Solution by Cardinal Health

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0187-4330 QR Code

< Prev: 0187-4303Next: 0187-4420 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.